glp 1 drugs and parkinson's disease A Big Week for GLP-1 - by Eric Topol GLP-1 Agonists: A New Frontier
Description
J Pharmacol Exp Ther 2006;317:11061113
Impact of High Glucose Levels and Glucose Lowering on Risk of Ischaemic Stroke: A Mendelian Randomisation Study and Meta-Analysis
[DOI] [PubMed] [Google Scholar] 552.Fang Y., Jiang D., Wang Y., Wang Q., Lv D., Liu J
A 72-week, double-blind phase 2 trial showed that once-daily administration of semaglutide had a significant therapeutic effect on NASH (193)
